The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Single-Cell Genome Sequencing Market During The Forecast Period?
The single-cell genome sequencing market has experienced swift expansion in recent years. Projections indicate it will grow from $2.83 billion in 2025 to $3.26 billion by 2026, achieving a compound annual growth rate (CAGR) of 15.2%. Historically, this growth can be linked to aspects such as early adoption within research, constraints in sequencing resolution, the significant expense of single-cell analysis, rising demand for personalized medicine studies, and increased partnerships in genomics.
The single-cell genome sequencing market size is poised for significant expansion in the coming years. This market is projected to reach $5.84 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.7%. The anticipated growth during this period stems from factors such as the advancement of high-throughput single-cell platforms, increased application in clinical diagnostics, integration with AI and bioinformatics, wider adoption in multi-omics studies, and a rise in drug discovery applications. Key developments expected in the forecast timeframe include a growing application in cancer research, deeper integration with multi-omics studies, broader adoption in drug discovery, the emergence of automated sequencing platforms, and an expansion of clinical diagnostics applications.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp
Which Key Factors Are Driving The Single-Cell Genome Sequencing Market Growth?
The growing incidence of cancer is expected to stimulate the expansion of the single-cell genome sequencing market moving forward. Cancer refers to a wide range of diseases characterized by the uncontrolled proliferation and division of aberrant cells. This condition arises from modifications in genes responsible for regulating cell division and maintaining normal cellular functions. Given that cancer is defined by genetic alterations, single-cell genome sequencing provides a tool to detect the specific genetic changes occurring in individual cancer cells. As an illustration, in January 2023, the American Cancer Society, a US-based entity dedicated to fighting cancer, reported approximately 1.9 million new cancer diagnoses and 609,360 cancer-related fatalities in the US in 2022. Furthermore, projections indicate that by 2040, there could be around 27.5 million new cancer cases and 16.3 million cancer deaths. Therefore, the escalating prevalence of cancer is anticipated to drive the growth of the single-cell genome sequencing market.
How Are Different Segments Classified In The Single-Cell Genome Sequencing Market Segment Analysis?
The single-cell genome sequencing market covered in this report is segmented –
1) By Type: Instruments, Reagents
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)
3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas
4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications
5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users
Subsegments:
1) By Instruments: Single-Cell Isolation Systems, Sequencing Platforms, Automation And Robotic Systems
2) By Reagents: Library Preparation Kits, Amplification Reagents, DNA Extraction Kits, Quality Control Reagents
Which Trends Are Guiding The Direction Of The Single-Cell Genome Sequencing Market?
Leading companies in the single-cell genome sequencing market are concentrating on advancing single cell proteomics. This emerging field aims to decipher the wide array of protein expression within individual cells. It involves integrating single-cell genomics with proteomics techniques to explore the connection between genomic information and protein expression at the individual cell level. For example, in October 2023, the UK-based biotechnology company Proteome Sciences plc unveiled SysQuant SCP, a commercial service for single-cell proteomics, which harnesses its TMTproTM isobaric labelling reagents. The SysQuant SCP pipeline generates and analyzes quantitative mass spectrometry data to reveal subtle variations in individual cells and among subpopulations of the same primary cell type. This data is expected to significantly deepen our understanding of the biological factors driving heterogeneity and evolution in disease and therapeutic response contexts, by identifying new therapeutic and diagnostic targets for personalized medicine.
Who Are The Companies Driving Activity In The Single-Cell Genome Sequencing Market?
Major companies operating in the single-cell genome sequencing market are F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.
Get The Full Single-Cell Genome Sequencing Market Report:
https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report
Which Region Represents The Largest Share Of The Single-Cell Genome Sequencing Market?
North America was the largest region in the single-cell genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Single-Cell Genome Sequencing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report
Browse Through More Reports Similar to the Global Single-Cell Genome Sequencing Market 2026, By The Business Research Company
Single Cell Analysis Market
https://www.thebusinessresearchcompany.com/report/single-cell-analysis-market
Whole Genome And Exome Sequencing Market Report
Metagenomic Sequencing Market Report
https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model